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Abstract  24 
Background: Brominated flame retardants (BFRs), are chemicals widely used in consumer 25 
products including electronics, vehicles, plastics and textiles to reduce flammability. 26 
Experimental animal studies have confirmed that these compounds may interfere with thyroid 27 
hormone homeostasis and neurodevelopment but to date health effects in humans have not 28 
been systematically examined.  29 
Objectives: To conduct a systematic review of studies on the health impacts of exposure to 30 
BFRs in humans, with a particular focus on children.  31 
Methods: A systematic review was conducted using the Medline and EMBASE electronic 32 
databases up to 1 February 2012. Published cohort, cross-sectional, and case-control studies 33 
exploring the relationship between BFR exposure and various health outcomes were included. 34 
Results: In total, 36 epidemiological studies meeting the pre-determined inclusion criteria 35 
were included. Plausible outcomes associated with BFR exposure include diabetes, 36 
neurobehavioral and developmental disorders, cancer, reproductive health effects and 37 
alteration in thyroid function. Evidence for a causal relationship between exposure to BFRs 38 
and health outcomes was evaluated within the Bradford Hill framework.  39 
Conclusion: Although there is suggestive evidence that exposure to BFRs is harmful to 40 
health, further epidemiological investigations particularly among children, and long-term 41 
monitoring and surveillance of chemical impacts on humans are required to confirm these 42 
relationships. 43 
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1. Introduction  44 
Brominated flame retardants (BFRs) are commonly used in electronics, clothes, toys, motor 45 
vehicles, plastics, and textiles to reduce flammability (Chen et al., 2009; Dirtu and Covaci, 46 
2010). This group of chemicals consists of tetrabromobisphenol A (TBBPA), polybrominated 47 
diphenyl ethers (PBDEs), polybrominated biphenyls (PBB), and hexabromocyclododecane 48 
(HBCD) (Dirtu and Covaci, 2010). Three commercial PBDE formulations have been 49 
produced: penta-BDE, octa-BDE and deca-BDE (U.S Department of Health and Human 50 
Services, 2004). The penta-BDE product was used mainly in flexible polyurethane foam for 51 
mattresses and cushioning, octa-BDE in the plastics industry in computer casings and 52 
monitors and deca-BDE in high impact polystyrenes and other materials for electronic and 53 
electrical appliances, the automotive industry, construction and building applications as well 54 
as textiles (U.S Department of Health and Human Services, 2004). These compounds are 55 
lipophilic and persistent and can concentrate in animal fats and fish species. The harmful 56 
health effects of these chemicals can be related to their persistency, bioaccumulation and 57 
biomagnification potential in humans (Eljarrat et al., 2004). BFRs are increasingly present in 58 
the environment and humans. The major routes of exposure are dietary sources, inhalation and 59 
ingestion through dust in indoor environments and occupational exposure (Birnbaum and 60 
Staskal, 2004).  61 
 62 
Despite cessation of penta- and octa-BDE manufacture in many developed countries, 63 
concentrations in humans have increased (Schecter et al., 2005). In Australia, BFRs have been 64 
in use since the 1970s but importation of penta- and octa-BDE products ceased in 2005 65 
(NICNAS, 2007). Nevertheless, concentrations in humans are reported to be higher than those 66 
found in Europe and Asia but lower than in North America with the congener, PBDE-47 the 67 
most prominent in human blood in Australia and overseas (Schecter et al., 2005; Thomsen et 68 
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al., 2002; Toms et al., 2009). In particular, concentrations of PBDEs are highly elevated in 69 
Australian children at four to five times that of adults (Toms et al., 2008). Other studies have 70 
also reported higher concentrations of BFRs in paediatric versus adult serum (Fischer et al., 71 
2006; Sjödin et al., 2008; Toms et al., 2009) and can most likely be attributed to breastfeeding 72 
and dust ingestion from mouthing behaviours and playing closer to ground level. Thus the 73 
dynamic physiology of children combined with the way they interact with their environment 74 
results in higher exposures than adults in the same environment (Landrigan et al., 2004). In 75 
addition, young children have decreased metabolic capacity to detoxify and eliminate 76 
environmental contaminants (Landrigan et al et al., 2004). Furthermore, the continuing 77 
growth and maturation of their immune and neurological systems make them especially 78 
vulnerable to the adverse effects of environmental exposures (Landrigan et al et al., 2004). 79 
The potential health consequences of this increased paediatric body burden remain largely 80 
unknown and require further investigation (Landrigan et al et al., 2004; Stapleton et al., 2005, 81 
2008; Toms et al., 2008), particularly in light of increasing evidence that many adult diseases 82 
may originate during foetal development and early childhood.  83 
 84 
A number of experimental animal studies have explored and identified the association 85 
between BFR exposure and adverse health effects (Blake, 2011; Canton et al., 2008; Chhabra 86 
et al., 1993; He et al., 2011a; Imai et al., 2009). Kim et al. (2009) reported that exposure of 87 
pregnant rats to PBDE-209 was linked to increased thyroid stimulating hormone (TSH) levels 88 
in their offspring. In rats, Thyroxine (T4) and Triiodothyronine (T3) were decreased in the 89 
study population when exposed to 0.3 mg/kg or more of PBB (Gupta et al., 1983). Reduced 90 
plasma T4 levels in male rats 10 and 20 days after exposure to PBB with subsequent 91 
disruption of normal homeostasis of the pituitary thyroid axis and PBB accumulation in the 92 
thyroid have also been observed (Allen-Rowlands et al., 1981). In rats, exposure to 93 
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commercial mixtures of BFRs have been associated with: alterations in thyroid hormone 94 
homeostasis; developmental neurotoxicity and neurobehavioral changes as well as 95 
reproductive health effects, including a delay in puberty and a decrease in ventral prostate and 96 
seminal vesicle weights at the high dose in male rats (Birnbaum and Staskal, 2004) leading to 97 
concerns over the potential impact on human health. 98 
 99 
Studies reviewing the current data on BFRs exploring the main sources, distribution, exposure 100 
pathways, and toxicity, as well as the potential health risks of exposure have been published 101 
(Birnbaum and Staskal, 2004; Daso et al., 2010; Kefeni et al., 2011; Legler and Brouwer, 102 
2003; Sjödin et al., 2003). Legler and Brouwer (2003) have identified BFRs as a possible 103 
endocrine disrupting chemical (EDC). Early life exposure to EDCs may lead to endocrine 104 
disorders or diseases particularly in children and during fetal development (Legler and 105 
Brouwer, 2003). Sjödin et al. (2003) and Daso et al. (2010) reviewed literature based on 106 
human exposure to PBDEs, including human exposure routes and levels. According to Sjödin 107 
et al. (2003), food intake was the main route of human exposure for adults and breast milk for 108 
young children. The majority of studies have reported the most dominant PBDE congener in 109 
human tissues to be PBDE-47 (e.g. Sjödin et al., 2003; Daso et al., 2010). The aim of the 110 
current study was to conduct a systematic review of the scientific literature to summarize the 111 
evidence relating to the possible relationship between exposure to BFRs and health outcomes 112 
in humans.  113 
 114 
2. Method 115 
The review was carried out using general recommendations from The Preferred Reporting 116 
Items for Systematic Reviews and Meta-Analyses (PRISMA) revision, which is an evidence-117 
based minimum set of items for reporting in systematic reviews and meta-analyses, with 118 
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reference to processing and reporting of results (Moher et al., 2009). The PRISMA checklist 119 
(see Supporting Information Text S1) was used as a guideline to report this systematic review.  120 
 121 
2.1. Inclusion and exclusion criteria 122 
This systematic review incorporated retrospective and prospective cohort studies, cross-123 
sectional and case-control studies meeting the following inclusion criteria: (1) reported 124 
original, empirical research published in a peer reviewed journal, (2) considered exposure to 125 
BFRs as a potential risk factor for loss of health, and (3) considered health outcomes for 126 
which standardized diagnostic criteria are available. The included studies reported effect size 127 
estimates and confidence intervals. Relevant articles included epidemiological studies 128 
exploring BFR exposure, with specific health outcomes, such as reproductive health, 129 
neurobehavioral and developmental disorders, cancer, diabetes and alterations in thyroid 130 
hormone levels.  131 
 132 
2.2. Search strategy description  133 
The electronic databases MEDLINE and EMBASE were searched for studies published up to 134 
1st. February 2012. The search strategy was developed in consultation with a librarian and the 135 
following keywords were included: exposure; brominated flame retardants; 136 
tetrabromobiphenol A; polybrominated biphenyl; polybrominated diphenyl ethers; and 137 
hexabromocyclododecane. The health consequences of exposure to BFRs in humans and 138 
specific diseases were not specified in the search ensuring that it was kept broad and inclusive 139 
(see Supporting Information Text S2). The search was not restricted to the English language, 140 
nor restricted by any other means. Articles in languages other than English were translated.   141 
 142 
2.3. Data collection  143 
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The full-text article of any study that appeared to meet the inclusion criteria was retrieved for 144 
closer examination. Two reviewers (YRK and LT) independently assessed articles for 145 
eligibility. Disagreements were resolved by consensus (YRK, LT, FH and RN). A 146 
standardized data extraction form was developed and data retrieved included: publication 147 
details (year of publication); country where study was conducted; methodological 148 
characteristics such as sample size and study design, exposure and outcome measures, type of 149 
BFR and chemical analysis, age, whether blood or breast milk samples were used, health 150 
outcome assessment and effect size with 95% confidence intervals. The coders were not 151 
masked to the journals or authors of the studies reviewed.  152 
 153 
3. Results 154 
3.1. Study selection 155 
In total, 1,502 potentially relevant journal articles were identified from the database search, 156 
and 5 additional studies were identified from reference lists. A total of 1,005 articles were 157 
screened after duplicates were removed. A further 913 records were then excluded mainly 158 
because they were animal or human cell line studies. Of 92 full-text articles assessed for 159 
eligibility, 36 met the inclusion criteria and reported effect size and uncertainty information 160 
(Figure 1).  161 
Insert Figure 1. PRISMA flow diagram showing process of study selection for inclusion in 162 
systematic review  163 
3.2. Study characteristics 164 
Among the 36 selected articles, there were 22 cohort studies, six cross-sectional studies and 165 
seven case-control studies. All but one study were published between 2000 and 2011. The 166 
majority of included studies (n=31) were from the United States of America (USA) with two 167 
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Swedish, one Taiwanese (Chao et al., 2010), one Spanish (Gascon et al., 2011) and one 168 
Norwegian (Eggesbo et al., 2011) study included. Although the majority of articles were 169 
conducted on PBDEs (n=20), and PBBs (n=16), one study also examined HBCD (Eggesbo et 170 
al., 2011). Seventeen child-related studies were extracted, and the studies explored the 171 
association between paediatric health and BFR exposure through a child or maternal BFR 172 
sample. BFR exposure in children was mostly determined via measurements obtained from 173 
mothers during lactation or pregnancy, with the exception of one study where samples were 174 
obtained from adolescents (12 – 19 years) (Chen et al., 2011). Study characteristics by five 175 
sub group health categories are presented in Tables 1-5. In addition, the general findings from 176 
each article were summarised in the ‘Study results’ column of Tables 1-5. Among the 36 177 
included studies, one study (Gascon et al., 2011) examined two health effects, and hence 178 
results of this study were presented for two health outcomes (Tables 1 and 5). 179 
3.3. Summary of health effects  180 
The health effects associated with exposure to BFRs were summarized into five sub groups: 181 
(1) thyroid disorders (2) diabetes (3) reproductive health (4) cancers and (5) neurobehavioral 182 
and developmental disorders. Chemical concentrations of BFRs varied from 0.2 to 85.8 183 
nanograms per gram of lipid (ng/g lipid). Studies varied in sample size, ranging from a total 184 
of 25 participants in the study by Zota et al. (2011) to 1,384 participants in the Michigan 185 
cohort by Vasiliu et al. (2006) (Tables 1-5).  186 
 187 
3.4. Results of individual studies and risk of bias within studies  188 
 189 
3.4.1. Thyroid disorders  190 
In total, nine epidemiological studies for thyroid disorders were extracted (Bloom et al., 2008; 191 
Chevrier et al., 2010; Chevrier et al., 2011; Eggesbo et al., 2011; Gascon et al., 2011; 192 
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Herbstman et al., 2008; Stapleton et al., 2011; Yard et al., 2011; Zota et al., 2011). Eight 193 
epidemiological studies for alterations in thyroid hormone levels and PBDEs, and one for 194 
thyroid disease and PBB (Yard et al., 2011) were examined (Table 1).  195 
 196 
Insert Table 1. Study Characteristics for Thyroid disorders 197 
Zota et al. (2011) identified that the sum of PBDEs were associated with increased TSH levels   198 
in pregnant women in Northern and Central California during the second trimester (ß = 0.40, 199 
95% CIs = -0.07 - 0.87). This study also found that decreased TSH was related to PBDE-207 200 
(ß = -0.72, 95% CIs =  -1.10 -  -0.34) whereas there was a weak and inconsistent  association 201 
between PBDEs and free T4 (ß = -0.02, 95% CIs =  -0.15 -  0.12) and total T4 (ß = 0.50, 95% 202 
CIs =  -1.04 -  2.04)  (Zota et al., 2011). As this was a pilot study with a sample size of 25, the 203 
results may be difficult to generalize. Stapleton et al. (2011) also reported a finding of an asso204 
ciation between PBDE exposure and TSH during pregnancy. It was observed that PBDE 47, 9205 
9 and 100 were correlated with elevated levels of free and total T4. Furthermore, positive asso206 
ciations were seen between increased levels of total trritiothyroxine (TT3: 178 nanogram per d207 
eciliter (ng/dL)) and PBDE-47 (OR = 1.30, 95% CIs = 1.00 - 1.69), and a negative relationshi208 
p between TT3 and 4-hydroxylated PBDE-49 (4-OH-BDE-49) (OR = 0.51, 95%CIs = 0.30 - 0209 
.86) (Stapleton et al., 2011). Interestingly, there were higher PBDE levels in non-Hispanic 210 
blacks compared to non-Hispanic whites and PBDE levels decreased with age (Stapleton et al., 211 
2011). Evidence also emerged for an association between PBDEs and neonatal thyroid hormo212 
ne levels. Herbstman et al. (2008) found no statistically significant relationship between total t213 
hyroxine measured in blood spots collected after birth and cord serum concentrations of PBD214 
E 47, 100 or 153. In children born by unassisted vaginal delivery, increased odds of low total t215 
hyroxine at 18 days of age but not at 2 days of age were associated with cord PBDE-153 (Her216 
bstman et al., 2008). In addition, TSH levels decreased with increased levels of PBDEs and P217 
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BDE 28, 47, 99, 100 and 153 concentrations in the sera of pregnant women around 27 weeks 218 
of gestation (Chevrier et al., 2010). Odds of subclinical hyperthyroidism were also elevated w219 
ith increased exposure to BDE 100 and BDE 153 (Chevrier et al., 2010). 220 
 221 
Increased levels of PBB after BMI adjustment were not statistically related to the incidence of 222 
thyroid diseases but women with thyroid disease were at an increased risk of developing 223 
diabetes (OR = 1.61, 95% CIs = 1.04 - 2.51) (Yard et al., 2011). Gascon et al. (2010) also 224 
indicated that the concentration of pre- and post-natal PBDEs was not related to alteration in 225 
thyroid hormone levels in children at 4 years of age from the USA. Three studies that 226 
examined PBDE exposure and alterations in thyroid hormone in neonates (Chevrier et al., 227 
2011; Eggesbo et al., 2011), and in recreational fishermen (Bloom et al., 2008) found no 228 
statistically significant association although further investigation was recommended (Bloom 229 
et al., 2008).  230 
 231 
3.3.2. Diabetes 232 
Three epidemiological studies examined PBDE and PBB exposure and diabetes (Lee et al., 233 
2010; Turyk et al., 2009; Vasiliu et al., 2006) (Table 2). Turyk et al. (2009) reported that there 234 
were no obvious associations between PBDEs and diabetes. However, the authors suggested 235 
that body burden of sum PBDEs can influence the impact of diabetes in persons with 236 
hypothyroid disease (Turyk et al., 2009). Lee et al. (2010) also found that PBB 153, the 237 
only PBB analysed, was linked to an increased risk of type 2 diabetes in the second (OR 238 
= 3.0, 95% CIs = 1.1 - 8.1, 10-16 pg/g PBB exposure) or third quartile (OR = 3.1, 95% 239 
CIs = 1.1 - 9.2, 17-23 pg/g PBB exposure) compared to the lower quartiles of less than 9 240 
pg/g PBB exposure in an adjusted model for age, sex, race and BMI at year 2. The 241 
quartiles referred to different serum concentrations of PBB 153 and ranged from <9 242 
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picograms per gram (pg/g) in the 1st quartiles to >23 in the 4th quartile (Lee et al., 2010). The 243 
Michigan Cohort is a cohort group potentially exposed to PBB via a food chain accident 244 
(ingestion of contaminated food in the early 1970s). Vasiliu et al. (2006) found no increased 245 
risk of developing diabetes among the Michigan cohort after 25 years of follow up. The 246 
authors acknowledge that they may have underestimated diabetes incidence in this population 247 
as those lost to follow up were older and had a higher BMI which are important risk factors 248 
for diabetes. However, no differences in distribution of PBB levels between those included in 249 
the analysis and those lost to follow up were detected (Vasiliu et al., 2006).  250 
Insert Table 2. Study Characteristics for Diabetes 251 
 252 
3.4.3. Reproductive health effects 253 
This review identified 17 epidemiological studies investigating associations between exposure 254 
to BFRs and reproductive health outcomes including: decreased birth weight (Blanck et al., 255 
2002; Givens et al., 2007; Harley et al., 2011; Sweeny and Symanski, 2007); fecundability 256 
(the ability to achieve and maintain pregnancy), (Harley et al., 2010); alteration in secondary 257 
sex ratio, defined as the proportion of male births (Terrell et al., 2009); spontaneous abortion 258 
(Small et al., 2007); alteration in age at menarche and tanner stage (Blanck et al., 2000); 259 
hypospadias (Carmichael et al., 2010); genitourinary conditions (Small et al., 2009); abnormal 260 
Pap Smear test (Jamieson et al., 2011); changes in menstruation characteristics (Davis et al., 261 
2005; Chao et al., 2010); benign breast disease (Kaiser et al., 2003); time to menarche (Chen 262 
et al., 2011), time to menopause (Blanck et al., 2004); and risk of endometriosis (Hoffman et 263 
al., 2007) (Table 3). 264 
Insert Table 3. Study Characteristics for Reproductive Health effects 265 
Direct and indirect effects of BFR exposure and reproductive health on paediatric health 266 
outcomes have been reported (Blanck et al., 2000; Chao et al., 2010; Chen et al., 2011; Harley 267 
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et al., 2010; Harley et al., 2011; Small et al., 2009). Blanck et al. (2000) divided the female 268 
participants into 6 groups (breast-fed & non-breastfed and low, medium & high prenatal PBB 269 
exposure). In the study, breastfed girls who were prenatally exposed to high levels of PBB 270 
had earlier development of pubic hair and onset of menarche than breastfed girls who were 271 
prenatally exposed to lower levels of PBB (Blanck et al., 2000). This relationship persisted 272 
after adjustment for potential confounders (Hazard ratio (HR) = 3.4, 95% CIs = 1.27 - 9.04) 273 
(where HR is the ratio of the hazard rates corresponding to the conditions described by the 274 
two levels of explanatory variables), (Blanck et al., 2000). Irregular menstrual periods have 275 
been correlated with higher concentrations of the sum of PBDE congeners and certain BDE 276 
congeners (from 183 to 209) (Chao et al., 2010). There is also evidence that higher 277 
concentrations of serum PBDEs (median of sum PBDE; 44.7 ng/g lipid) could be related to 278 
earlier ages at menarche (Relative Risk (RR) = 1.60, 95% CIs = 1.12 - 2.28) (Chen et al., 279 
2011). Small et al. (2009) showed that sons of women exposed to high levels of PBB (> 5 280 
ppb) were twice as likely to report any male genitourinary condition (hernias, hydroceles, 281 
cryptorchidism, hypospadias, varicocele) compared with sons of the least exposed women (≤ 282 
1 ppb; OR = 2.0; 95% CIs, 0.8–5.1) after adjustment for gestational age at birth. This risk 283 
increased when sons born after the exposure but before the mother’s serum PBB measurement 284 
was taken were excluded (OR = 3.1, 95% CIs = 1.0 - 9.1). Harley’s study (2011) concluded 285 
that infant birth weights decreased when maternal concentrations of PBDE 47, 99 and 100 286 
were increased. In this study, every 10 fold increase in maternal PBDE-47 concentration was 287 
associated with a 115 g decrease in birth weight in a continuous measurement (β = -115.4, 288 
95% CIs = -229 - -2). In addition, PBDEs were also found in the serum of 95% of pregnant 289 
participants, and could be related to reduced fecundability (Harley et al., 2010). In particular, 290 
there was a significantly decreased odds of fecundability for PBDE-100 (OR = 0.6, 95% CIs 291 
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= 0.4 - 0.9), PBDE-153 (OR = 0.5, 95% CIs = 0.3 - 0.8), and sum of the PBDE congeners in 292 
this study (OR = 0.7, 95% CIs = 0.5 - 1.0). In a study of adult women (25-44 years), Davis et 293 
al. (2005) reported that there was an association between higher PBB of women with weight 294 
loss in the past year and 3.55 days shorter cycle length (95% CIs = -6.45 - -0.65) but this data 295 
was obtained from a very small sample (N=4). There was no identified evidence between 296 
PBB exposure and menstrual cycle characteristics.  297 
 298 
A number of studies found either non significant or no relationship between BFR 299 
concentrations and reproductive health. This included no association between maternal serum 300 
PBB and gestational age (Givens et al., 2007; Sweeny and Symanski, 2007) although high 301 
levels of maternal serum PBB were related to lower birth weight. Terrell et al. (2009) 302 
identified 922 offspring born to 496 Michigan cohort mothers from linkage with electronic 303 
birth records and, for 366 of these offspring, they identified 208 fathers who were also 304 
participants in the PBB cohort. The authors reported a 6% increase in the odds of a male birth 305 
for a 10 μg/L increase in the natural log of combined parental exposure to PBBs which was 306 
not statistically significant after adjustment for year of offspring's birth, parental BMI and 307 
offspring born to the same mother or father (OR = 1.06, 95% CIs = 0.97-1.17). Small et al. 308 
(2007) concluded that there was no risk of spontaneous abortion in 529 women exposed to 309 
PBDEs after adjustment for maternal age at conception, age at menarche, and prior infertility 310 
described as the inability to achieve pregnancy. There was also no evidence for a relationship 311 
between prenatal PBB exposure and height or weight in girls (Blanck et al., 2002). 312 
Hypospadias, a congenital malformation in the urethral opening in males, was not statistically 313 
correlated with maternal PBDE exposure, but the authors suggested that a larger study might 314 
be warranted in order to identify the relationship (Carmichael et al., 2010). Jamieson et al. 315 
(2011) reported an increased risk for self-reporting an abnormal Pap Smear among highly 316 
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exposed women (13 µg/L PBB exposure) compared to women with non-detectable PBB 317 
exposure after adjustment for polychlorinated biphenyl (PCB) concentrations, age at the 318 
interview and smoking history, although it did not reach statistical significance (HR = 1.23, 319 
95% CIs = 0.74 - 2.06).  In studies by Hoffman et al. (2007), Blanck et al. (2004), and Kaiser 320 
et al. (2003) no evidence was found for an association between PBB exposure and 321 
endometriosis, time to menopause, abnormal Pap test results, or benign breast disease.  322 
 323 
3.4.4. Cancers  324 
Exposure effects and cancers were investigated in three case-control studies (Hardell et al., 325 
2006; Hardell et al., 2009; Hurely et al., 2010) and one nested case-control study from the 326 
Michigan cohort accidentally exposed to PBB (Hoque et al., 1998). Each study examined 327 
different cancers, i.e. Non-Hodgkin lymphoma, testicular cancer, benign breast cancer, 328 
digestive system and other cancers. Of these studies, one examined PBB (Hoque et al., 1998) 329 
and three examined PBDEs (Hardell et al., 2006; Hardell et al., 2009; Hurely et al., 2010). No 330 
study examined paediatric cancer (Table 4).  331 
Insert Table 4. Study Characteristics for Cancer 332 
Non-Hodgkin Lymphoma (NHL), a lymphoid malignancy, was not associated with PBDE 333 
exposure (OR = 0.7, 95% CIs = 0.4 - 1.2) after controlling for age, sex and BMI (Hardell et 334 
al., 2009). There was no selection bias as the Swedish population registry was used to select 335 
participants with no time gap for recruiting the cases and controls (Hardell et al., 2009). In an 336 
earlier study, Hardell et al. (2006) investigated in utero exposure to persistent organic 337 
pollutants (POPs) and testicular cancer risk, and reported an increased concentration of 338 
PBDEs in mothers whose sons were diagnosed with testicular cancer (OR = 2.5, 95% CIs = 339 
1.02 - 6.0). However, a relationship between in utero exposure to PBDEs and testicular cancer 340 
was difficult to establish because increased concentrations of PBDEs have been found in the 341 
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human food chain (Hardell et al., 2006). Thus, the authors further suggested that adjustment 342 
for food habits would be required because food consumption (fish, dairy products, meat, 343 
poultry and eggs), the main exposure pathway of POPs (approximately 95% of POP exposure 344 
comes by food), may have caused an increase in PBDE concentration in mothers (Hardell et 345 
al., 2006). A small case-control study by Hurley et al. (2011) found no evidence of a 346 
relationship between PBDE concentrations in adipose tissue and the risk of breast cancer. 347 
Although Hoque et al. (1998) reported a 2.4 fold increased breast cancer risk with exposure to 348 
PBB levels of 4~20 ppb this was not statistically significant (OR = 2.41, 95% CIs = 0.92 – 349 
6.30) after adjusting for age, family cancer history, cigarette smoking, alcohol drinking, and 350 
baseline serum PCB levels in the multivariate analysis. There was no association between 351 
PBB exposure and prostate, lung, larynx, colon, female reproductive system, urinary system, 352 
leukaemia, melanoma, and ovarian cancers. However, this study showed an increased dose-353 
response relationship between risk of digestive system cancers and higher serum PBB in the 354 
multivariate analysis. A dose response relationship between PBB concentration and 355 
lymphoma was also apparent after univariate analysis (Hoque et al., 1998).  356 
 357 
3.4.5. Neurobehavioral and developmental disorders  358 
Four studies explored neurobehavioral and developmental disorders, such as alteration in 359 
neurodevelopment, autism, and alteration in neuropsychological status with inconsistent 360 
outcomes reported (Fitzgerald et al., 2011; Gascon et al., 2011; Hertz-Picciotto et al., 2011; 361 
Herbstman et al., 2010). The number of sample participants varied between 96 and 470 362 
individuals (Table 5).  363 
Insert Table 5. Study Characteristics for Neurobehavioral and developmental disorder 364 
Key neurobehavioral effects of exposure to different types of PBDEs were examined in three 365 
studies (Gascon et al., 2010; Fitzgerald et al., 2011; Herbstman et al., 2010). Gascon et al. 366 
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(2010) found that postnatal exposure to PBDE-47 was statistically associated with an 367 
increased risk of symptoms of the attention deficit subscale of Attention Deficit Hyperactivity 368 
Disorder (ADHD) symptoms at four years of age (RR = 1.8, 95% CIs = 1.0 - 3.2), but did not 369 
affect hyperactivity symptoms. In a prospective cohort study, Herbstman et al. (2010) 370 
recruited women who were pregnant on 11 September 2001 and subsequently delivered 371 
around the World Trade Center (WTC), and examined environmental samples from pre-and 372 
post-9/11 near the WTC site. A statistically significant association between children exposed 373 
to higher levels of PBDE 47, 99 and 100 in their cord blood and a lower score on mental and 374 
physical-developmental tests was observed between the ages of 12 to 48 months, and at age 375 
72 months after adjusting for exact age of the child at testing, ethnicity, IQ of mother, sex of 376 
child, gestational age at birth, maternal age, exposure to environmental tobacco smoke, 377 
maternal education, material hardship, and breast-feeding (Herbstman et al., 2010). 378 
Specifically, for every unit increase in PBDE-47 there was a 2.1-3.1 decrease in points on 379 
developmental indices and the increase was statistically significant. Significant associations 380 
were reported for 12-month Psychomotor Development Index (PBDE-47), 24-month Mental 381 
Development Index (MDI) (PBDE-47, 99, and 100), 36-month MDI (PBDE-100), 48-month 382 
full-scale and verbal IQ (PBDE-47, 99, and 100) and performance IQ (PBDE-100), and 72-383 
month performance IQ (PBDE-100) (Herbstman et al., 2010). In a study of older adults in 384 
New York, no overall evidence was found between sum PBDEs and neuropsychological 385 
status (Fitzgerald et al., 2012). Similarly, there were no significant associations between 386 
PBDE exposure and autism and developmental delay although children diagnosed with 387 
autism and developmental delay in all control groups had higher levels of PBDEs (Hertz-388 
Picciotto et al., 2011).  389 
 390 
4. Discussion 391 
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To our knowledge, this is the first systematic review of the scientific literature exploring the 392 
human health consequences of BFR exposure. Of the 36 studies examined, 17 paediatric 393 
studies were included. Evidence for causality between exposure to BFRs and health outcomes 394 
was evaluated within the Bradford-Hill framework, on the grounds of the following important 395 
criteria: biological plausibility, the temporal relationship of the association, strength and 396 
consistency of the association, evidence of a biological gradient or dose–response 397 
relationship, and consideration of alternate explanations (Hill, 1965).  398 
 399 
Plausibility 400 
Animal experiments allow us to assess the biologic plausibility of the associations observed in 401 
epidemiologic studies. Overall, there is strong plausibility for a relationship between exposure 402 
to BFRs and various outcomes in humans and mechanisms of action have been inferred from 403 
animal and in vitro models.  404 
 405 
Thyroid hormones, including triiodothyronine (T3) and thyroxine (T4), regulate protein 406 
synthesis, metabolism, body growth and development. When released into the bloodstream 407 
thyroid hormones can occur bound to transport proteins, or as free T3 (FT3) and free T4 (FT4). 408 
Thyroid-stimulating hormone (TSH) regulates the synthesis and secretion of thyroid hormone 409 
by the thyroid gland and in turn thyroid hormone negatively influences TSH secretion through 410 
a negative feedback loop (Gilbert et al., 2012; Henrichs et al., 2013). TSH levels can also be 411 
moderated by the hypothalamus through release of the thyrotropin releasing hormone (TRH). 412 
Interactions between the hypothalamo-pituitary-thyroid axis can be inhibited or stimulated by 413 
natural physiological responses or by exposure to chemical pollutants, including PBDEs. 414 
PBDEs are structurally similar to T4 (Gill et al., 2004) and can cross the placenta and may 415 
interfere with thyroid production and receptor binding leading to altered hormone levels. 416 
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Animal studies have shown that these exposures generally result in decreased T4 levels and or 417 
increased TSH levels. For instance, Blake et al. (2011) found increased T3 and T4 418 
concentrations among F1 female offspring of mothers treated by commercial product DE-71. 419 
 420 
Thyroid hormones play a critical role in neurodevelopmental processes, such as neurogenesis, 421 
cell migration, synaptic development, neuronal growth, and myelination. The foetus cannot 422 
produce TSH before the second trimester of pregnancy and is entirely dependent on maternal 423 
thyroid hormone. The fetal thyroid begins to function during week 12 of pregnancy, but the 424 
maternal thyroid gland contributes thyroid hormone throughout gestation (Gilbert et al., 2012; 425 
Henrichs et al., 2013). The developing central nervous system is sensitive to disruption of 426 
thyroid homeostasis throughout the embryonic and fetal periods, continuing through early 427 
post-natal life. Small fluctuations in thyroid hormone levels at critical windows of 428 
susceptibility may have long lasting health consequences and maternal thyroid dysfunction 429 
during early pregnancy may affect a child’s cognitive development (Gilbert et al., 2012; 430 
Henrichs et al., 2013).  431 
 432 
An in vitro study of human neural progenitor cells (hNPCs) (Schreiber et al., 2010), provided 433 
evidence that exposure to PBDEs can cause disruption of hNPCs development through 434 
endocrine disruption of cellular thyroid signalling. In rats, a relationship between PBDE-47 435 
exposure and learning and memory alteration has been observed (He et al., 2011b). He et al. 436 
(2011a) also found that chronic exposure of parent zebrafish to low doses of PBDE-209 led to 437 
neurobehavioral changes in their offspring. 438 
 439 
Evidence from human cell lines and animal laboratory studies seems to support a possible 440 
increased cancer risk in humans. For example, Li et al. (2012) found that PBDE-209 can lead 441 
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to cancer cell proliferation in breast, cervical and the normal Chinese Hamster Ovary cell 442 
lines. National Toxicology Program (NTP, 1986) reported that there was an increased dose-443 
response relationship between deca-BDE and liver neoplastic nodules in rat experiments, and 444 
increased acinar cell adenoma of the pancreas was also detected in male rats exposed to high-445 
dose of deca-BDE. Further evidence is that B6CF1 mice fed PBDE-209 had increased 446 
incidence of follicular cell hyperplasia of the thyroid gland, which can raise thyroid cancer 447 
risk (Capen, 1992; NTP, 1986). The extrapolation of effects from high-dose rodent tests to 448 
predict possible risk in humans following low-dose exposures remains contentious. Barber et 449 
al. (2006) investigated the effects of PBDEs (congeners 47, 99, 153, 183 and 209) in the 450 
oestrogen-receptor-positive breast carcinoma MCF-7 cell line and found that low-dose PBDE 451 
concentrations appeared capable of damaging cell genomes. Although data is limited, PBDEs, 452 
through their endocrine-disrupting effects, may exert an effect through a hormonal pathway 453 
for hormonally mediated cancers such as that of the breast (Hurley et al., 2011). The 454 
International Agency for Research on Cancer (IARC) has classified PBBs as probably 455 
carcinogenic to humans with supporting evidence from other relevant data, namely 456 
mechanistic similarity with polychlorinated biphenyls classified as carcinogenic to humans 457 
(IARC, 2013).  458 
 459 
Reproductive health effects and endocrine disruption were increased in rats and fish exposed 460 
to PBDEs (Blake et al., 2011; He et al., 2011a). Blake et al. (2011) investigated the low dose 461 
effects of the penta-BDE mixture DE-71 on reproductive health and thyroid hormone among 462 
pregnant and lactating rats. In addition, chronic low dose PBDE-207 exposure affected 463 
parental gonad development and locomotion in F1 offspring (He et al., 2011a). Animal data 464 
suggests perinatal PBB exposure may have antiandrogenic effects through increased 465 
metabolism and decreased responsiveness to testosterone (Newton et al., 1982). There is also 466 
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evidence that BFRs may act as environmental diabetogenic pollutants in rat adipocytes 467 
(Hoppe and Carey, 2007).  468 
Temporality 469 
The availability of prospective studies provides evidence of a temporal relationship between 470 
exposure to BFRs and later neurodevelopmental effects in children. In a prospective study, 471 
associations between prenatal exposure to PBDEs and subsequent lower scores on mental and 472 
physical developmental tests in children were statistically significant (Herbstman et al., 2010). 473 
Using a prospective design and data from the Michigan cohort, Small et al. (2009) also 474 
showed that women who were accidentally exposed to PBBs from 1973 to 1974 subsequently 475 
exposed sons in utero and then linked these exposures to self-reported genitourinary 476 
conditions in the sons. The association between PBB and genitourinary conditions was 477 
stronger among sons with whom PBB exposure was estimated forward to the time of 478 
conception using a decay model. Unfortunately, this study may have been subject to reporting 479 
bias in those mothers and sons may be more likely to report a genitourinary condition if they 480 
had higher PBB exposure as all participants were informed of their serum PBB level at 481 
enrollment. For diabetes, however, two prospective studies report conflicting results. In a 25 482 
year follow up analysis of the Michigan cohort, Vasiliu et al. (2006) did not find an 483 
association between PBB serum levels at enrollment and self-reported diabetes incidence. In a 484 
nested case control study, however, Lee et al. (2010) measured PBB in serum collected in 485 
1987–1988 from participants in the Coronary Artery Risk Development in Young Adults 486 
(CARDIA) cohort study and compared the 90 controls who remained free of diabetes with 90 487 
cases diagnosed with diabetes many years later in 2005–2006 and found a significant 3 fold 488 
increased risk. 489 
 490 
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However, the majority of the studies were retrospective cohorts and case-control studies or 491 
cross-sectional. Temporal relationships, by definition, were not possible to determine in cross-492 
sectional studies and reverse causality, in which certain diseases such as diabetes may 493 
increase accumulation or inhibit the clearance of these chemicals could not be ruled out (Lee 494 
et al., 2010).  495 
 496 
Strength of the Association 497 
Although weak associations between BFR exposure and alterations in thyroid function have 498 
been reported, stronger associations have been reported for diabetes (Lee et al., 2010), cancer, 499 
neurodevelopmental and reproductive health effects. In most instances, these associations 500 
remained significant when confounding variables were considered. The limited number of 501 
studies and small sample sizes (only 11 studies with sample size >450 persons), however, are 502 
an important concern. 503 
 504 
Consistency of the Association 505 
Although a few studies reported significant effects for their study endpoints, consistency of 506 
associations was difficult to evaluate due to differing exposure levels, health parameters and 507 
exposure and outcome measurements. It is also notable that European countries, such as 508 
Sweden, Norway, and Spain had lower exposure levels than in the USA making it difficult to 509 
compare study outcomes from different regions of the world.  510 
BDEs were associated with raised TSH levels in two different and independent study 511 
populations (Zota et al., 2011; Herbstman et al., 2008). Zota et al. (2011) found positive 512 
associations between TSH and concentrations of lower brominated PBDE congeners although 513 
associations with total and free T4 were mostly weak and inconsistent. Similarly, Herbstman 514 
et al. (2008) reported that prenatal BDE exposure was positively associated with TSH and 515 
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negatively with TT4 and free T4 among infants born by spontaneous unassisted vaginal 516 
delivery. The observed relationships were consistently in the same direction even though not 517 
always individually statistically significant. Three other studies, however, did not find 518 
statistically significant associations (Bloom et al., 2008; Chevrier et al., 2011; Eggesbo et al., 519 
2011) while Stapleton et al. (2011) found the opposite, in other words positive associations 520 
between BDEs and T4 levels. Although the study by Chevrier et al. (2010) did not find a 521 
significant association between BDEs and T4, they did observe a similar trend to the Stapleton 522 
et al. (2011) study with an inverse association between BDEs and TSH as low TSH levels is 523 
associated with high T4 levels. Again, differences in exposure matrices, timing of measures of 524 
thyroid hormones, PBDE congeners measured and analytical and statistical methods make 525 
direct comparisons difficult and hence more studies with appropriate exposure assessment are 526 
needed before a definitive conclusion can be made regarding the consistency of the 527 
association.  528 
 529 
Comparisons of human and animal studies reveal inconsistent results regarding the 530 
relationship between thyroid hormones and neurodevelopment. It is important to note that 531 
animal studies generally report hypothyroxinemic effects of exposure to PBDEs whereas 532 
varied effects of PBDE exposure on thyroid function in humans (inhibitory, stimulatory or 533 
none) causing both increases and decreases in thyroid hormones and TSH levels have been 534 
reported in the literature. Physiological differences between rodent models and humans may 535 
explain why animals and humans respond differently to these exposures and rodents may be 536 
more susceptible to thyroid hormone disruption following exposure to PBDE. Furthermore, 537 
complications of labour and delivery can alter thyroid hormone function in mothers and 538 
infants at time of delivery. Herbstman et al. (2008) showed that prenatal PBDE exposures 539 
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were associated with reduced T4 levels among infants born by unassisted vaginal delivery and 540 
intrapartum stress related to delivery mode may conceal hormonal effects of PBDEs. 541 
 542 
The evidence for carcinogenic effects in humans was inconsistent with studies showing an 543 
increasing dose-response relation for ‘digestive system’ cancer risk and lymphoma risk, but 544 
not for other sites of cancers, including prostate, lung and larynx, breast, ‘female reproductive 545 
system’ or ‘urinary system’ (Hoque et al., 1998). An increased OR of 2.5 (95% CIs = 1.02 – 546 
6.0) was reported for testicular cancer (Hardell et al., 2006).  Other studies, however, showed 547 
no association with non-Hodgkin Lymphoma, testicular cancer or breast cancer (Hardell et al., 548 
2009; Hurely et al., 2010). For neurobehavioral and developmental disorders, two out of the 549 
four included studies reported significant impairment of their specific health parameters in 550 
childhood with BFR exposure (Gascon et al., 2010; Herbstman et al., 2010). In particular, 551 
Herbstman et al. (2010) found a statistically significant association between children exposed 552 
to higher levels of PBDE 47, 99 and 100 in their cord blood and a lower score on mental and 553 
physical-developmental tests at ages 12 to 48 months and 72 months. Although the other two 554 
included studies did not show significant associations, it is important to note that the 555 
Fitzgerald et al. (2011) study investigated neuropsychological status in adults 55-74 years of 556 
age and the Hertz-Picciotto et al. (2011) study was carried out on a small sample of less than 557 
100 children. 558 
Dose-response Relationship 559 
Hoque et al. (1998) found an increasing dose-response relationship for digestive system 560 
cancer risk after adjustment for age, family cancer history, cigarette smoking, alcohol 561 
drinking, and baseline serum PCB level: OR of 8.23 (95% CI 1.27-53.3) for PBB exposure of 562 
4-20 parts per billion (ppb); 12.3 (95% CI = 0.80-191) for exposures of 21-50 ppb, and 22.9 563 
(95% CI 1.34-392) for PBB exposure levels over 50 ppb. Univariate analysis for PBB level 564 
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and lymphoma risk also showed a dose-response relation: OR 3.24 (95% CI 0.24-95.9), OR 565 
20.5 (95% CI 1.51-608), and OR 32.6 (95% CI 3.33-861), for the corresponding PBB 566 
exposure categories, respectively. However, it is important to note that this study did not 567 
observe dose-response relationships for the many other cancer sites included and also found 568 
no relationship between baseline serum PBB levels and excess cancer risk for all sites 569 
combined.  570 
In addition, a typical linear dose-response pattern is not predicted for many of these chemicals 571 
and non-monotonic (non-linear) responses and low-dose effects have typically been 572 
associated with compounds with endocrine disrupting effects (Vandenberg et al., 2012). In a 573 
study of several POPs, including PBB, POPs showed nonlinear associations with diabetes risk 574 
with highest risk observed in the second quartiles suggesting low-dose effects (Lee et al., 575 
2010). This may also explain the different effects observed in some animal studies exposed to 576 
high doses and human populations exposed to low doses of these chemicals.  577 
Consideration of Alternative Explanations 578 
It is also important to consider that individuals are exposed to a mixture of hormonally active 579 
chemicals, often at chronic low doses and that exposure profiles are also affected by diet and 580 
migration history. It is therefore difficult to consider a single chemical as a marker of total 581 
exposure. Many of these endocrine disrupting chemicals also act additively and the multiple 582 
and complex effects of these chemicals are dose-dependent and contextual (Soto, 2010). 583 
Studies that accounted for confounding variables still found significant associations between 584 
exposure to BFRs and adverse outcomes in exposed populations. Herbstman et al. (2007) 585 
found comparatively lower levels of PBDEs in infants of Asian mothers living in Baltimore, 586 
USA, and hence adjustment for ethnicity may be of particular importance given its impact on 587 
health effects and exposure levels. With regard to PBDEs and thyroid function, there is also 588 
the possibility that other unmeasured factors such as iodine status may affect the relationship.  589 
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Assessment of Evidence 590 
We used the grading system for assessment of carcinogens developed by the World Cancer 591 
Research Fund (WCRF 1997) as a guideline for evaluation of the level of evidence. We 592 
concluded that ‘possible evidence’ exists for a relationship between BFR exposure and 593 
alteration of thyroid hormone levels, neurodevelopmental disorders, diabetes and reproductive 594 
health, particularly decreased birth weight and longer time to pregnancy and possibly cancer 595 
but more well designed research is needed to support these tentative but biologically plausible 596 
associations.  597 
 598 
This systematic review not only provides an important summary of the literature relevant to 599 
the human health effects of BFRs, it highlights research gaps and helps to define priorities for 600 
future research, particularly with regard to children’s health.  601 
 602 
There are however certain limitations. Firstly, this review may be subject to publication bias 603 
because non-significant findings are less likely to be published. Furthermore, only significant 604 
estimates are reported in many studies meaning that effects that cannot be validated 605 
statistically were not included. Another limitation is that, since individuals cannot be 606 
randomly allocated to case groups, the influence of confounding variables cannot be fully 607 
evaluated. Different studies controlled for a range of possible confounders including socio-608 
economic status, behavioural risk factors, exposure to other environmental toxicants and 609 
ethnicity making comparisons difficult. Furthermore, we cannot exclude that residual 610 
confounding or unmeasured potential confounders may still remain and that some of the effect 611 
of these chemicals on health may still be explained by confounding. Other unmeasured POPs 612 
could also play a role in the development of these diseases as serum concentrations of POPs 613 
are highly correlated in the general population (Lee et al. 2010). Isolating health effects to a 614 
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particular BFR or combination of BFRs in the absence of other exposures is complex making 615 
the results of these kinds of studies complex and analytically challenging. Furthermore, the 616 
possibility of reverse causation between the health outcomes and BFR levels cannot be 617 
discounted in many studies, particularly if exposure was assessed close to the time of 618 
diagnosis as certain health outcomes may affect BFR levels. A well-designed large 619 
prospective study such as the Michigan Cohort has the added benefit that since exposure was 620 
measured closely after the accident and health effects were measured many years after 621 
exposure occurred the risk of reverse causality is reduced. Furthermore, since PBB exposure 622 
was a result of an accident, exposure levels are more random and less likely to be associated 623 
with potential confounders such as diet. Exposure to other POPs such as PCBs was also 624 
measured in this cohort enabling the assessment of confounding by other POPs. 625 
 626 
It is also difficult to generalise the association between BFRs and health outcomes, as most 627 
articles investigated PBDEs or PBB only, and excluded HBCD and TBBPA. We found only 628 
one study (Eggesbo et al., 2010) investigating the relationship between HBCD in human 629 
breast milk and TSH. Limited available data on TBBPA and HBCD may be due to the slower 630 
development of analytical techniques required for determining concentrations of these 631 
chemicals meaning that these are not routinely analysed. Improvement in analytical 632 
techniques means that examination of health effects and exposure to these chemicals is now 633 
improved and will be increasingly undertaken. Therefore, encouragement of further 634 
epidemiological studies examining PBDEs and PBB but also TBBPA and HBCD are 635 
recommended and would enable a more accurate assessment of the health effects of all BFRs. 636 
BFR concentrations were estimated as categorical variables in many selected studies which 637 
could lead to loss of power because of reduced variability (Frøslie et al., 2010) and most 638 
studies required larger sample sizes to observe associations. Thus, continuous measurements 639 
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in large studies are recommended to overcome this. In addition, many included studies were 640 
cross-sectional which by definition cannot prove a temporal relationship between exposure 641 
and outcomes. In addition, timing of the sampling is also important to consider as for some 642 
health outcomes such as reproductive health effects, levels measured for exposure assessment 643 
may not reflect early life exposure. Large birth cohort studies are needed allowing prospective 644 
measurement of the environmental effects of these chemicals including biomonitoring data in 645 
order to determine the most vulnerable period or critical window of exposure for biological 646 
effects. This will also allow better understanding of exposure–response relationships ensuring 647 
adequate adjustment for confounders, assessment of specific chemicals in more detail, and 648 
also improve understanding of potential mechanisms of action and gene – BFR interactions in 649 
order to explore a causal connection.  650 
 651 
Different classes of BFR (e.g. PBB and PBDEs) from populations at differing levels of 652 
exposure (e.g. accidental and background exposure) were used in studies, from a combination 653 
of blood and breast milk samples, in infants, children, pregnant women, mother-child pairs 654 
(investigating association between maternal PBDE concentrations and health outcomes in 655 
their children) and adults with occupational exposures. The BDE congeners that were reported 656 
and included in the sum PBDE results also differed across studies with 5 BDE congeners, (28, 657 
47, 99, 100 and 153) examined by Chevrier et al. (2010), whereas Stapleton et al. (2011), 658 
included 4 BDE congeners (47, 99, 100 and 153). Consistent examination of congeners for 659 
the sum of BDE congeners is also recommended for more accurate comparison. These 660 
methodological differences together with the limited number of studies presenting effects for 661 
similar health outcomes as well as differences in exposure levels between different 662 
populations made it difficult to combine studies in a meta-analysis.  663 
 664 
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5. Conclusion and Recommendations 665 
Although epidemiological data are limited, this overview of the evidence suggests a possible 666 
relationship between BFR exposure and serious health consequences, namely cancer, such as 667 
digestive system cancers and lymphoma, reproductive health effects, alteration in thyroid 668 
function, neurobehavioral and developmental outcomes in children, and diabetes. Ongoing 669 
research of the impact of BFR exposure particularly on thyroid function is important given the 670 
evidence of its effect on brain development and neurological health (Porterfield, 2000). 671 
Relatively little is known about the health effects of chronic low level exposure to these 672 
chemicals, particularly among children and there is, consequently, urgent need to provide 673 
more information for the evaluation of their potential threat to children’s health. Certainly, 674 
consistent monitoring and development of methodology that result in ease of sample 675 
collection in children as well as more consistent evaluation of exposure and health effects in 676 
children and adults would be necessary. It is recognized that there are challenges in working 677 
with children particularly with respect to, obtaining informed consent, sampling and the 678 
collection of sufficient sample volume in the case of neonates and infants (Heffernan et al., 679 
2013). The development and evaluation of non-invasive sampling matrices as well as 680 
increased collaboration with researchers conducting paediatric research is needed to facilitate 681 
BFR monitoring in children. 682 
 683 
More stringent regulatory requirements to demonstrate that a chemical does not cause a partic684 
ular health effect and demonstration of no health effects at chronic low doses should be establi685 
shed. Currently, information on the toxicity of many chemicals is not completely understood, 686 
especially the mode of action. Studies on the adverse health impacts of many chemicals are sc687 
arce and it is important to investigate the synergistic health effects of  combinations of differe688 
nt environmentally relevant concentrations of chemicals. Also the  minimum health risk level 689 
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concentrations of many chemicals still need to be confirmed. It is, however, recognized that c690 
hemical management regulations must be based on reasonable evidence, and mandatory chem691 
ical testing, and user guidelines should be considered to protect potential users in a pre-market692 
 setting (Council on Environmental Health, 2011). 693 
 694 
In conclusion, limited epidemiological data, weak and inconsistent associations across studies, 695 
lack of comparative and large studies with appropriate exposure assessment in humans and in696 
complete understanding of biological mechanisms precludes the establishment of a causal rela697 
tionship when assessing the evidence through conventional epidemiological approaches. How698 
ever, biologically plausible associations between BFRs and health outcomes, widespread prod699 
uction and use of BFRs, the increasing contamination of the environment, in combination wit700 
h their persistence and bioaccumulation, and important data gaps regarding elevated exposure701 
s in children warrant special consideration of BFRs as emerging risks to health. A precautiona702 
ry approach towards exposure of both mothers and children seems warranted with long-term 703 
monitoring and ongoing surveillance to fully characterize risks to health. 704 
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